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A B S T R A C T
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease with a poor prognosis and an undefined
etiopathogenesis. Oxidative stress contributes to alveolar injury and fibrosis development and, because
transition metals are essential to the functioning of most proteins involved in redox reactions, a better
knowledge of metal concentrations and metabolism in the respiratory system of IPF patients may provide a
valuable complementary approach to prevent and manage a disease which is often misdiagnosed or diagnosed in
later stages.
The present review summarizes and discusses literature data on the elemental composition of bronchoalveo-
lar lavage (BAL), induced sputum and exhaled breath condensate (EBC) from patients affected by IPF and
healthy subjects. Available data are scanty and the lack of consistent methods for the collection and analysis of
lung and airways lining fluids makes it difficult to compare the results of different studies. However, the
elemental composition of BAL samples from IPF patients seems to have a specific profile that can be
distinguished from that of patients with other interstitial lung diseases (ILD) or control subjects. Suggestions
are given towards standard sampling and analytical procedures of BAL samples, in the aim to assess typical
element concentration patterns and their potential role as biomarkers of IPF.
1. Introduction
During biomolecular evolution, several elements such as Cr, Co, Cu,
Fe, I, Mn, Mo, Ni, Se or Zn were selected to carry out a wide range of
biological functions and traces of them (ng/g or μg/g) became essential
for cell metabolism, including the activation or inhibition of enzymatic
reactions, and the regulation of gene and membrane functions. All
living organisms and tissues require the intake of essential elements in
proper proportions: an excess, deficiency, or imbalance may disturb the
cell functions and may seriously affect health [1,2]. Risks of developing
adverse health effects are usually evaluated indirectly, by biomonitor-
ing the dietary intake and/or the inhaled amounts of airborne trace
elements. However, determining actual element concentrations in
biological samples such as blood, urine, feces, bone, or cerebrospinal
fluid has the advantage to better reflect their bioavailability and the
amounts that can reach target tissues.
During the last decades, knowledge of metal transport proteins
(including metallothioneins) and the transfer of their different chemical
forms to different organs and tissues has significantly improved [3,4].
Unlike other organs, lungs are directly and continuously exposed to
high oxygen concentrations, exogenous oxidants and pollutants; thus,
they have the greatest susceptibility to oxidative stress and pollutant
toxicity, from which they protect themselves through the action of own
constitutive and inducible antioxidants and detoxification mechanisms
[5]. The biological effects of inhaled metals occur at the sites of first
contact and it is therefore necessary to study the metabolism and
impact of essential and toxic metals in the respiratory system rather
than by traditional exposure biomarkers such as blood or urine. Among
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essential trace elements, the understanding of Fe metabolism is the
most advanced, and studies on lung physiology, dysfunction and injury
usually consider only this metal [6,7]. Iron plays a fundamental role in
the respiratory chain, as reactive forms of the metal are accumulated in
the lung for cellular growth and proliferation, and decreased intracel-
lular Fe concentrations suppress the generation of epithelial cell surface
plasmin, which is essential for repairing damaged lung tissue [8].
However, if not appropriately chelated, Fe can promote the formation
of harmful free radicals. Many other trace elements are involved in the
regulation of Fe metabolism and contribute to the functioning and
protection of the lung. Thus, a better knowledge of the occurrence and
distribution of trace elements in the respiratory system and changes
occurring during lung diseases could give new insights for diagnostic,
therapeutic and preventive actions, especially for severe and complex
diseases such as idiopathic pulmonary fibrosis (IPF).
IPF is a complex interstitial lung disease of unknown etiology,
characterized by severe and progressive fibrosis of the alveolar inter-
stitium with histopathological or radiological patterns typical of usual
interstitial pneumonia. Probably, it is the result of complex interactions
between genetic and environmental factors [9,10]. Several infectious,
occupational and toxic etiologies have been suggested and epidemio-
logical studies have shown associations between IPF development and
cigarette smoke, wood and metal dust, silica and other inhaled
environmental agents as well as co-morbidities with gastroesophageal
reflux and type 2 diabetes [11,12]. In general, it is believed that IPF
results from the aberrant activation of injured alveolar epithelial cells
producing mediators that promote the proliferation of fibroblasts and
fibrocyte recruitment with the formation of myofibroblastic foci, the
accumulation of excessive extracellular matrix and lung remodeling
[13–15]. Although barely investigated, the assessment of trace element
distribution in the lung tissue and lining fluids could probably be an
useful prognostic/predictive tool providing additional and complemen-
tary information with respect to genetic, proteomic, or molecular
biology approaches. The chemical analysis of lung tissue samples is
the most realistic way to assess the elemental composition of lung, but
this invasive approach is rarely used for the diagnosis of IPF. Through
an up-to-date literature survey of data on the elemental composition of
airway secretions and breath condensates, this paper aims at providing
an overview of available knowledge on trace element concentrations in
IPF patients and an evaluation of their potential role as biomarkers of
the disease.
2. Trace elements in BAL samples
Bronchoalveolar lavage (BAL) is a rather simple method to obtain a
biological matrix for histopathological and chemical analysis. Although
the chemical composition of this non-homogenous matrix can be
contaminated by element contribution from the saline solution and
the bronchoscope, working with BAL samples, instead of small lung
biopsies, increases the sample representativeness and as a rule, reduces
contamination by blood elements. Surveys on the elemental composi-
tion of BAL began 30 years ago [16,17] and although already in 1987
Sabbioni et al. [18] investigated on what should be the most suitable
technique to analyze samples from differently exposed workers and the
composition of the saline solution used for bronchoalveolar lavage,
standardized methods for the collection and analysis of BAL are still
lacking. Due to the inhomogeneous nature of samples, some authors
[19] suggested that the amount of a trace element per 1000 macro-
phages should be the best way to establish baseline concentrations in
BAL; on the contrary, other authors [20] found that concentrations (μg/
l) of several elements in BAL were unrelated to age, sex, recovered
volume of fluid, as well as to the total number of cells and alveolar
macrophages. Thus, element concentrations in BAL have been ex-
pressed in different ways (mass/volume, mole/volume or on the basis
of total cell number or number of macrophages), and for a given
element available data are variable and difficult to compare. Harlik
et al. [21] analyzed Zn, Cu and Fe concentrations (expressed in μg/kg)
in 157 whole samples of BAL obtained for other diagnostic purposes.
The supernatant was separated from cells and solid particles by
centrifugation. The results showed that metal concentrations in the
whole sample and the supernatant were linearly correlated and almost
all elements (about 90%) were in the supernatant. With few exceptions,
the increase of Cu concentrations was associated to a decrease of Zn
content, and low Fe concentrations were found in a few BAL samples
with high Zn levels. Analytical determinations were performed by
atomic absorption spectrophotometry without any pre-treatment and in
most samples the concentrations of Cu, Fe and Zn were< 15, 120 and
200 μg/kg, respectively. However, as shown in Table 1 for BAL samples
from healthy controls, the results of analytical determinations are
affected by pre-treatment methods, and their complete chemical
digestion in a Teflon bomb or irradiation followed by NAA analysis
[17,18] give the highest values. Since the study by Sabbioni et al. [18]
it was known that the elemental composition of BAL changes among
subjects working in different industries as well as between control
groups and patients affected by sarcoidosis. Thus, reliable comparisons
of the elemental composition of BAL can only be made among samples
collected within homogeneous groups of persons (e.g. patients with the
same disease, workers with the same occupational exposure), pre-
treated and analyzed with the same procedures. To evaluate if data on
BAL elemental composition, integrated with those from clinical exam-
inations, can be used as a diagnostic tool for lung diseases Bargagli et al.
[22] compared Cd, Cr, Cu, Fe, Mn, Ni, Pb, V, and Zn concentrations in
BAL samples from control subjects and from patients with pulmonary
Langerhans cell histiocytosis (PLCH), sarcoidosis, and IPF. Among the
analyzed elements, the concentrations of Cd and V were below
detection limits; those of the other elements varied widely and some
outlier values were also found, especially for Cu and Mn. BAL from IPF
patients showed significantly lower median concentrations of Cr, Mn,
Ni and Zn and a slightly higher Fe content than control subjects. Results
expressed in ng/macrophages showed the highest Fe content and the
lowest Mn and Zn contents in samples from IPF patients (Table 3) [22].
3. The elemental composition of induced sputum
Induced sputum is a heterogeneous matrix obtained by inducing
expectoration through the inhalation of nebulized hypertonic saline.
This approach is less invasive than bronchoscopy and BAL and allows
the collection of a fluid phase with a mixture of cells and solutes which
are considered representative of the larger airways. If in the clinical
practice the differential cell count in BAL is widely accepted and
recommended as a diagnostic/prognostic tool for sarcoidosis, PLCH, IPF
and other ILD [23,24], the cell count and FeNO values in induced
Table 1
Mean concentrations of Cu, Fe, and Zn (μg/l;± SD) in whole BAL samples from control
subjects, following different pre-treatments and analytical methods.
Metal (μg/l) Sample pre-treatment Analytical
techniquea
References
Cu 215 ± 122 dissolved in Teflon
bomb
ETASS/ICP [18]
2.81 ± 3.02 slight acidification with
HCl
ETASS [22]
Fe 758 Irradiation NAA [17]
508 ± 204 Irradiation NAA [18]
32.3 ± 26.1 slight acidification with
HCl
ETASS [22]
Zn 695 Irradiation NAA [17]
510 ± 120 Irradiation NAA [18]
8.21 ± 4.31 slight acidification with
HCl
ETASS [22]
a ETASS: Electrothermal Atomic Absorption Spectrophometry; ICP: Inductively
Coupled Plasma Spectroscopy; NAA: Neutron Activation Analysis.
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sputum may serve as valuable additional tools in obstructive lung
diseases [25]. Gray et al. [26] analyzed Cu, Fe, Mn and Zn concentra-
tions in sample of induced sputum from patients with cystic fibrosis
(CF), non-CF bronchiectasis, asthma, COPD, and 20 healthy controls.
Element concentrations were determined by ICP-OES and the results
indicated a statistically significant increase of Zn and Fe concentrations
in CF and non-CF bronchiectasic patients versus controls. The major
weakness of this method is that it is impossible to establish if elements
in the sputum originate from injured lung tissue or from luminal
inflammatory cells. Furthermore, other possible sources of elements
such as micro-vascular leakage, cell membrane channelopathies or
contamination by inhaled particulates, cannot be disregarded. As the
elemental composition of expectorated sputum can be affected by
oropharyngeal contamination, this matrix seems less suitable than
BAL to assess the pattern of element concentrations in IPF patients,
but, to our knowledge, the issue has never been approached in the
literature.
4. Elements in exhaled breath condensate
Exhaled breath consists of a gaseous phase with many volatile
compounds and a liquid phase containing aerosol particles with slightly
volatile and nonvolatile compounds. Some breath volatile compounds
have a distinctive smell that has been used as indicator of several
diseases since the time of Hippocrates. Dogs can discriminate exhaled
breath samples from subjects with and without lung cancer [27] and
very sensitive electronic noses are now available for smellprint
identification [28]. If identification of volatile substances, particularly
NO, was the main objective of breath studies, in recent years a growing
interest has been devoted to the analysis of exhaled breath condensate
(EBC). During normal tidal breathing, small aerosol droplets
(< 0.3 μm) join the vapor stream passing over the mucus layer lining
the lung and airways, and the droplets can be collected through the
cooling of the exhaled breath [29,30]. Most of the condensate consists
of water vapor, but also contains non volatile compounds such as
inflammatory mediators, and trace elements. Like the analysis of BAL or
induced sputum, investigating EBC samples can provide useful informa-
tion on lung pathobiology and on airways and lung exposure to
airborne persistent pollutants in occupational and environmental
settings [31,32]. This absolutely non-invasive approach allows to study
patients of any age, even at home. Main concerns on determining the
elemental composition of EBC are the lack of standardized procedures
for the collection of representative samples and risk of their contam-
ination by elements from saliva and sampling devices. Most available
data on the elemental composition of EBC refer to occupationally
exposed workers [30,32–35]. Some authors [36,37] analyzed concen-
trations of serum pneumoproteins and several elements in EBC samples
from asymptomatic smokers and patients with obstructive pulmonary
diseases (including COPD and asthma). In COPD patients the EBC
content of Fe and Cu was lower than in control nonsmokers and Cu
levels positively correlated with values of the forced expiratory volume
(FEV1). Comparisons between concentrations of essential trace ele-
ments and toxic metals in EBC samples from 33 healthy subjects, 22
patients with sarcoidosis, 15 with non-specific interstitial pneumonia
and 19 with IPF showed only small overall differences among different
groups of patients [37]. However, in EBC samples from patients with
interstitial lung diseases of unknown etiology (all non-smokers or ex-
smokers), the concentrations of Ni, Si and Cr were significantly higher
and those of Fe, Cu, and Se significantly lower than in EBC from healthy
non-smokers. In particular, IPF patients also showed a lower EBC
content of Mo than controls and a significant relationship between Fe
concentrations in EBC and total lung capacity (TLC; %). Average EBC
concentrations of Cu, Fe and Zn (0.10, 0.30, and 2.1 μg/l, respectively)
were much lower than those in BAL samples from IPF patients.
Moreover, in IPF patients the BAL samples had significantly lower
(p < 0.01) median concentrations of Cr, Mn, Ni and Zn than controls
[22], whereas in EBC samples [37] the content of these elements was
higher or in the same range of those in healthy non-smoker subjects.
To evaluate the potential role of the elemental composition of
induced sputum and EBC in giving insight into respiratory disorders
such as IPF, it is mandatory to define normal element concentrations in
samples from healthy adult subjects. However, as shown for BAL in
Table 1, available literature data for these two biological matrices in
control groups are highly variable (Table 2). Median values of Cu, Fe
and Zn concentrations in the supernatant of induced sputum are an
order of magnitude higher than that in EBC samples, but, element
concentrations show the same pattern: Zn > Fe > Cu > Mn. In BAL
supernatant Fe concentrations are four times higher than those of Zn
(Table 1) and a much higher Fe/Zn ratio (about 15) has recently been
reported [38] for the ‘normal’ composition of lung tissue (Table 2).
Mumby et al. [39] determined the content of pro-oxidant Fe in both
BAL and EBC of patients undergoing cardiopulmonary bypass surgery
and found in all samples a decreasing trend of values pre- to post-
surgery. However, no correlation was found between the pro-oxidant Fe
levels of the two matrices and it was supposed that this discrepancy was
due to different areas of the respiratory system sampled with BAL and
EBC.
5. Oxidative stress and IPF
It is currently thought that the development of IPF is due to
persistent stimuli or injury followed by abnormal reepithelialization
and dysregulated remodeling of the extracellular matrix and several
lines of evidence in animal models and patients indicate the involve-
ment of oxidative stress in alveolar injury, inflammation and fibrosis
development [40–42]. Increased concentrations of lipid peroxidation
products, oxidized proteins and an altered antioxidant enzyme status or
the depletion of glutathione, the most abundant low-molecular-weight
antioxidant, have often been reported in epithelial lining fluid of IPF
patients [43–47]. Moreover, serum levels of reactive oxygen species
(ROS) negatively correlate with pulmonary function in IPF and may
predict disease severity [48]. Transition metals are essential for the
function of most proteins involved in redox reactions, and when
mechanisms regulating their metabolism (uptake, transport, storage
Table 3
Metal concentrations (μg l−1; average ± SD of
total metal concentrations) in BAL from patients
affected by diffuse pulmonary diseases (references
22,25).
Patients
Cr 2.69 ± 0.86
Cu 4.54 ± 4.50
Fe 24.2 ± 13.9
Mn 5.39 ± 8.82
Ni 1.70 ± 1.41
Pb 10.1 ± 17.1
Zn 6.01 ± 3.37
Table 2
Concentrations of Cu, Fe, Mn and Zn (μg/l; range and median value) in induced sputum
(supernatant), and EBC samples from healthy adult subjects, and ‘normal’ values (in μg/g,
dry weight) in mineralized lung tissues from living donors.
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and excretion) are altered, they can bind to different protein sites or be
replaced by other elements at their natural binding sites [49]. Some
metal ions and especially Fe2+ and Cu2+ are involved in enzymes
participating in redox reactions and in the conversion of active O2-
containing compounds, whereas other ions such as Ca2+ and Zn2+ are
targeted to other enzymes or transcription factors and behave as non-
redox ions [49]. There is evidence of a disordered Fe homeostasis in IPF
patients. Kim et al. [6], for instance, observed Fe deposition in
association with alveolar septal capillary density and pulmonary
hypertension in non-fibrotic lung tissue (from biopsies or explants)
from 149 IPF patients. Puxeddu et al. [50] analyzed total Fe concentra-
tions in BAL samples from 47 IPF patients and 14 healthy controls (the
BAL supernatant was mineralized with 15 μl of HNO3 0.2% and the
results of analytical determinations were normalized to the volume of
epithelial lining fluid recovered by lavage, using urea as marker of
dilution) [51]. Total Fe concentrations were significantly higher in
never-smoking or ever-smoking IPF patients than in never-smoking
healthy controls and were in the same range as in healthy current
smokers. However, no relationship was found between Fe accumulation
in BAL from IPF patients and their tobacco smoke history. Cell counts
showed a significantly higher number of Fe-laden alveolar macrophages
and macrophage hemosiderin accumulation in IPF BAL samples than in
controls. Hemosiderin content was significantly higher in patients with
elevated artery pressure, likely indicating vascular damage and pul-
monary veno-occlusive diseases [50]. However, Fe metabolism and
homeostasis can be altered by acute or chronic lung injury as well as by
changes in O2 availability (hypoxia and hyperoxia) [7,52]. Lungs are
the site of massive O2 exchange and have large blood supplies and
peculiar molecular mechanisms for the regulation of Fe metabolism and
the balance between oxidants and antioxidants [7]. For instance,
systemic Fe-deficiencies are characterized by low Fe concentrations in
serum and liver, but not in the lung [53]. Upon Fe exposure,
concentrations of transferrin, which imports Fe from the airways into
the lung epithelial cells and exports the metal to the outside, increases
in serum, but not in the pulmonary system [54]. The lung can probably
regulate Fe metabolism through transferrin receptors located in the
bronchial epithelium, macrophages, and lymphoid tissues. Unlike the
intestinal Divalent Metal Transporter 1 (DMT1), the transcripts of this
Fe binding protein in airways and alveolar epithelium do not appear to
be highly regulated by the Fe status [54,57].
6. Metabolism of transition metals in the lung
Understanding metal metabolism in the lung and airways is
complicated by peculiar and partly unknown mechanisms involved in
the redox balance in an environment affected by the concomitant
impact of inhaled elements and those arising from vascular leak or
released by necrotic airway cells or bacteria. Inhaled metals originate
from a number of external sources and differ greatly in their physico-
chemical characteristics and bioavailability. Anyhow, when compared
to the elemental composition of BAL from control subjects, samples
from IPF patients show significantly lower Cr, Mn, Ni and Zn
concentrations and slightly higher Fe and Cu concentrations (expressed
as μg/l; ng/cellx106 or ng/macrophages) [22]. Iron and Cu produce in
vivo hydroxyl radicals and this pattern of element concentrations in IPF
patients likely indicate the presence of free radicals and oxidative
stress. Iron is the most versatile cofactor in biological redox reactions
and when not appropriately chelated it can promote the formation of
harmful free radicals [55,56]. Copper is an essential co-factor for
oxidation-reduction reactions and an extracellular Cu-containing SOD
(EC-SOD) occurs in the lung; Cu is also involved in the maintenance of
Fe homeostasis. To prevent an excessive production of ROS, several Cu
chaperones regulate the cellular uptake and metabolism of the metal.
Copper deficiency can compromise (directly or indirectly) the oxidant
defense system by decreasing the activity of Cu/Zn-SOD, ceruloplasmin,
catalase, Se-dependent glutathione peroxidase (Se-GPX), and ROS
scavengers such as metallothioneins or glutathione [58]. Furthermore,
the reduced activity of Cu/Zn-SOD can promote the formation of
peroxynitrite, a potent initiator of oxidative damage, by decreasing
the content of bioactive NO which plays an important role in the
regulation of the vascular tone [59]. Manganese is another element
promoting the production of antioxidants (i.e., the mitochondrially
expressed SOD) and ROS. It is chemically and structurally similar to Fe,
however, Mn2+ ions are more stable than Fe2+ ions in water solutions
and are less likely to undergo a spontaneous redox cycling. Iron and Mn
share many protein transporters such as DMT1 and as a rule, during low
Fe bioavailability there is a Mn accumulation; conversely, altered Mn
uptake or metabolism can disrupt the homeostasis of Fe and other
transition metals [60]. However, Fe deficiency in the lung does not
enhances the pulmonary uptake of Mn and Fe and Mn absorption seem
to be mediated through different mechanisms [60]. Among analyzed
element in BAL from IPF patients [22], Fe/Mn concentration ratio was
three times higher than in samples from control subjects. Probably, the
decrease of Mn concentrations was due to the oxidative stress and the
disruption of transition metal homeostasis. Moreover, the three SODs
occurring in the lung (cytosolic Cu/Zn, mitochondrial Mn, extracellu-
lar) have specific functions and the Mn-SOD is induced during acute
inflammatory stages of the lung parenchyma, but its antioxidant
defense is probably impaired during the progression of fibrogenesis
[61]. Chromium (VI) is carcinogenic, however in the lung it is
efficiently reduced to Cr (III) by ascorbate, glutathione or cysteine
[62] and these reactions can produce different ROS species [63].
Although Cr (III) competes with Fe for a binding site in transferrin,
Cr supplementation does not seem to affect Fe nutritional status [64].
Nickel is another potentially toxic metal and much of its toxicity is
associated with interferences with the metabolism and physiological
processes of Mn, Zn, Ca and Mg. Chronic inhalation exposure to Ni
dusts and aerosols contributes to respiratory diseases (asthma, bron-
chitis, sinusitis and pneumoconiosis), and although lower concentra-
tions were measured in BAL from IPF patients than in control subjects,
it is known that Ni can cause formation of free radicals in both human
and animals with modifications to DNA bases, enhanced lipid perox-
idation and altered Ca and sulphydryl homeostasis [65].
Zinc is a component of more than 300 enzymes with catalytic,
structural and regulatory functions and is involved in numerous aspects
of cellular metabolism. Zinc acts as an antioxidant by protecting
sulphydryl groups of proteins against free radical attack or by reducing
the formation of free radicals through the replacement of Cu or other
redox-active metals from their binding site [66]. It can reduce the
formation of free radicals through the inhibition of the NADPH oxidase,
the induction of metallothioneins or the formation of the Cu/Zn-SOD,
where Cu provides the catalytic activity and Zn plays a critical
structural role. Through the up-regulation of a Zn-finger protein
(A20) and the reduced production of inflammatory cytokines, Zn
behaves also as an anti-inflammatory agent [67]. Macrophages (M2
phenotype) produce high levels of H2O2 and He et al. [68] showed that
Cu/Zn-SOD polarizes macrophages to this phenotype making the
generation of H2O2 generation in alveolar macrophages a critical factor
in the pathogenesis of pulmonary fibrosis. In IPF patients Cu/Zn-SOD
and Mn-SOD are upregulated whereas EC-SOD is practically absent in
fibrotic area and fibrotic foci, suggesting its depletion in places where
the oxidative burst is particularly strong [46]. The structural remodel-
ing of lung tissues is mediated by metalloproteases and in BAL of IPF
patients there is an increase in different proteases, especially matrix
metalloproteinases-7 (or matrilysin), which contributes to lung epithe-
lial damage [46,69]. Considering that most metalloproteases require Zn
as divalent cations and that many other transition metals are involved
in the oxidative stress and protease/antiprotease imbalance, a better
knowledge of metal occurrence and metabolism in the lung of IPF
patients will be very useful for an improved diagnosis, therapeutic and
preventive actions against a disease associated with high morbidity and
mortality. Selenium is a metalloid with properties of both a metal and a
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non- metal, it seems advisable to analyze this element in future studies
because Se-glutathione peroxidases seems highly efficient in defense
against oxidative stress [70].
7. Research perspectives and conclusions
Although available data on trace metal concentrations in BAL,
induced sputum and EBC appear scanty and highly variable, this survey
indicates that the chemical composition of BAL would probably help to
differentiate the IPF pattern from that of other pulmonary diseases and/
or healthy control subjects. The element concentration pattern both in
sputum and EBC (Zn > Fe > Cu > Mn) is different from those
reported for BAL and lung tissue (Fe > Zn > Cu) and does not
support current thoughts about the involvement of oxidative stress in
alveolar injury and IPF pathogenesis. The increase in free radicals is
associated to a disordered homeostasis of Fe as shown by increased
concentrations in BAL of IPF patients, a higher number of Fe-laden
alveolar macrophages and greater macrophage hemosiderin accumula-
tion than in controls. Increased Fe deposition has been detected in lung
biopsies from 149 IPF patients. The increase in free radicals and
oxidative stress are likely responsible for the significant decrease of
Zn, Mn, and Cr concentrations in BAL samples. Zinc is involved in
numerous aspects of cellular metabolism, acts as an antioxidant and is
involved in the structural remodelling of lung tissue through metallo-
proteases. Manganese also promotes the production of antioxidants
such as the mitochondrially expressed Mn-SOD, which is induced by
acute inflammatory stages of the lung parenchyma, although its
antioxidant defense is probably impaired during the progression of
fibrogenesis. Chromium is not a true antioxidant, however Cr (III)
competes with Fe for a binding site in transferrin. Thus, concentrations
of transition metals in BAL from IPF patients can likely play a role,
complementary to traditional biological approaches, as a prognostic/
predictive tool. However, available literature data are limited and
further studies on BAL samples from a larger population of IPF patients
and controls are needed to establish reference values and typical
patterns of element concentrations. Reliable comparisons among results
of different studies were the main problem in reviewing the available
literature on the elemental composition of BAL. Future research will
require standardized methodology for the pre-treatment and analysis of
samples, and the interpretation of results for specific groups of patients
and control subjects in relation to data from their clinical examination
and diagnosis, lifestyle, occupational and environmental settings.
BAL is a complex, non-homogenous matrix and reliable assessment
of its chemical composition is also hampered by possible contamination
of samples by the saline solution and blood or elements released by the
bronchoscope, disposable syringes and test-tubes. Direct determination
by sensitive analytical methods and limited sample handling (to reduce
the risks of contamination) provided reliable and accurate assays of
trace element concentrations in BAL samples. Whenever possible, it
seems advisable to collect BAL samples from subjects that are not under
pharmacological treatments and without concomitant pathologies. In
order to standardize the procedure and to evaluate concentrations of
Cd, Cr, Cu, Fe, Mn, Ni, Pb, V and Zn in broncho alveolar lavage it is
important to kept refrigerated at−20 °C and slightly acidified with HCl
for example before analysis by atomic absorption spectrophotometry.
Representative BAL sub-samples can be therefore stored and cells
should be separated from the supernatant. The latter can be analyzed
for trace element concentrations by different techniques (ETAAS, ICP-
MS, ICP-OES or NAA); however, to obtain reliable comparisons among
samples, it seems necessary to analyze always total concentrations of
elements through a complete mineralization of samples. BAL samples
must be colorless to exclude contamination by elements in the blood; a
suitable Standard Reference Material and the saline solution used for
instillation must be digested and analyzed together with BAL samples.
Although most studies on the chemical composition of BAL have only
considered Fe, Cu, and Zn concentrations, it seems necessary to analyze
other elements playing a role in the IPF development such as Ca, Co, Cr,
Mg, Mo, Ni, and Se. Together with the chemical analyses of the
supernatant, in BAL subsamples it is necessary to perform differential
cell counts and enzyme assays in the fluid fraction. By such compre-
hensive approach, applied to a large population of patients and
controls, it will possible to establish the role of the elemental composi-
tion of BAL as prognostic biomarker of IPF.
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